Pancreatic Cancer Research

ResearcherNanjing Drum Tower HospitalActive in the last 2 years

Yudong Qiu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-8227-9322; OpenAlex author ID A5108999846. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 3 papers

Papers 4

  1. CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer. Co-author DOI 10.1016/j.canlet.2025.217713↗
  2. Segment Like A Doctor: Learning reliable clinical thinking and experience for pancreas and pancreatic cancer segmentation. Co-author DOI 10.1016/j.media.2025.103539↗
  3. Radiotherapy and immune microenvironment crosstalk in pancreatic cancer: a comprehensive review of current insights and future directions. Co-author DOI 10.3389/fimmu.2025.1619946↗
  4. MUC1 promotes glycolysis through inhibiting BRCA1 expression in pancreatic cancer. Last author DOI 10.1016/s1875-5364(20)30019-4↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Juan Du · 1 shared paper, 2025 · strength 0.37
  2. Yucheng Xu · 1 shared paper, 2025 · strength 0.37
  3. Neng Tang · 2 shared papers, 2020–2025 · strength 0.35
  4. Xiaoping Yang · 1 shared paper, 2025 · strength 0.28
  5. Zhenghua Cai · 1 shared paper, 2025 · strength 0.28
  6. Yingying Cao · 1 shared paper, 2025 · strength 0.28
  7. Liwen Zou · 1 shared paper, 2025 · strength 0.28
  8. Yixuan Zhang · 1 shared paper, 2025 · strength 0.20
  9. Wei Wei · 1 shared paper, 2025 · strength 0.20
  10. Jiatong Tang · 1 shared paper, 2025 · strength 0.20
  11. Chao Yan · 1 shared paper, 2025 · strength 0.20
  12. Hexing Hang · 1 shared paper, 2025 · strength 0.20
  13. Hao Cheng · 1 shared paper, 2025 · strength 0.20
  14. Xiao Fu · 1 shared paper, 2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.